Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety
Therapeutic Advances in Gastroenterology
Published online on April 20, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.